Both in Pharmaceuticals
Ernexa Therapeutics vs Revelation Biosciences
Over the past year ERNA returned −95.4% and REVB returned −89.5%; their daily moves had a correlation of -0.01.
ERNA −95.4% REVB −89.5%Growth of $1, one year, split-adjusted
| Metric | ERNA | REVB |
|---|---|---|
| Price | $2.04 | $3.75 |
| Market cap | $2.4M | $2.1M |
| Today | −3.48% | 0.00% |
| 1 month | −31.2% | −33.1% |
| 6 months | −97.9% | −52.2% |
| Year to date | −93.2% | −83.3% |
| 1 year | −95.4% | −89.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 79.1% | 551.3% |
| Short % of float | 2.1% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).